186 related articles for article (PubMed ID: 37701824)
1. The evolution of SARS-CoV-2 and the COVID-19 pandemic.
Si Y; Wu W; Xue X; Sun X; Qin Y; Li Y; Qiu C; Li Y; Zhuo Z; Mi Y; Zheng P
PeerJ; 2023; 11():e15990. PubMed ID: 37701824
[TBL] [Abstract][Full Text] [Related]
2. Impact of Genetic Variability in ACE2 Expression on the Evolutionary Dynamics of SARS-CoV-2 Spike D614G Mutation.
Huang SW; Miller SO; Yen CH; Wang SF
Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33374416
[TBL] [Abstract][Full Text] [Related]
3. Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein.
Liu J; Chen X; Liu Y; Lin J; Shen J; Zhang H; Yin J; Pu R; Ding Y; Cao G
Infect Dis Poverty; 2021 Aug; 10(1):112. PubMed ID: 34419160
[TBL] [Abstract][Full Text] [Related]
4. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.
Zhai X; Sun J; Yan Z; Zhang J; Zhao J; Zhao Z; Gao Q; He WT; Veit M; Su S
J Virol; 2020 Jul; 94(15):. PubMed ID: 32404529
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms and epidemiology of COVID-19 from an allergist's perspective.
Hosoki K; Chakraborty A; Sur S
J Allergy Clin Immunol; 2020 Aug; 146(2):285-299. PubMed ID: 32624257
[TBL] [Abstract][Full Text] [Related]
7. Evolution of SARS-CoV-2 Envelope, Membrane, Nucleocapsid, and Spike Structural Proteins from the Beginning of the Pandemic to September 2020: A Global and Regional Approach by Epidemiological Week.
Troyano-Hernáez P; Reinosa R; Holguín Á
Viruses; 2021 Feb; 13(2):. PubMed ID: 33557213
[TBL] [Abstract][Full Text] [Related]
8. Dynamics of binding ability prediction between spike protein and human ACE2 reveals the adaptive strategy of SARS-CoV-2 in humans.
Xue X; Shi J; Xu H; Qin Y; Yang Z; Feng S; Liu D; Jian L; Hua L; Wang Y; Zhang Q; Huang X; Zhang X; Li X; Chen C; Guo J; Tang W; Liu J
Sci Rep; 2021 Feb; 11(1):3187. PubMed ID: 33542420
[TBL] [Abstract][Full Text] [Related]
9. Molecular Epidemiology of SARS-CoV-2: The Dominant Role of Arginine in Mutations and Infectivity.
Ridgway H; Ntallis C; Chasapis CT; Kelaidonis K; Matsoukas MT; Plotas P; Apostolopoulos V; Moore G; Tsiodras S; Paraskevis D; Mavromoustakos T; Matsoukas JM
Viruses; 2023 Jan; 15(2):. PubMed ID: 36851526
[No Abstract] [Full Text] [Related]
10. SARS-CoV-2 strategically mimics proteolytic activation of human ENaC.
Anand P; Puranik A; Aravamudan M; Venkatakrishnan AJ; Soundararajan V
Elife; 2020 May; 9():. PubMed ID: 32452762
[TBL] [Abstract][Full Text] [Related]
11. The variants question: What is the problem?
Zella D; Giovanetti M; Benedetti F; Unali F; Spoto S; Guarino M; Angeletti S; Ciccozzi M
J Med Virol; 2021 Dec; 93(12):6479-6485. PubMed ID: 34255352
[TBL] [Abstract][Full Text] [Related]
12. Topological Analysis for Sequence Variability: Case Study on more than 2K SARS-CoV-2 sequences of COVID-19 infected 54 countries in comparison with SARS-CoV-1 and MERS-CoV.
Sarkar JP; Saha I; Seal A; Maity D; Maulik U
Infect Genet Evol; 2021 Mar; 88():104708. PubMed ID: 33421654
[TBL] [Abstract][Full Text] [Related]
13. The extent of molecular variation in novel SARS-CoV-2 after the six-month global spread.
Bui NN; Lin YT; Huang SH; Lin CW
Infect Genet Evol; 2021 Jul; 91():104800. PubMed ID: 33677109
[TBL] [Abstract][Full Text] [Related]
14. Rampant C→U Hypermutation in the Genomes of SARS-CoV-2 and Other Coronaviruses: Causes and Consequences for Their Short- and Long-Term Evolutionary Trajectories.
Simmonds P
mSphere; 2020 Jun; 5(3):. PubMed ID: 32581081
[TBL] [Abstract][Full Text] [Related]
15. Uncovering the impact of SARS-CoV2 spike protein variants on human receptors: A molecular dynamics docking and simulation approach.
Zaheer M; Ali N; Javed H; Munir R; Jamil N
J Infect Public Health; 2023 Oct; 16(10):1544-1555. PubMed ID: 37566991
[TBL] [Abstract][Full Text] [Related]
16. Priming of SARS-CoV-2 S protein by several membrane-bound serine proteinases could explain enhanced viral infectivity and systemic COVID-19 infection.
Fuentes-Prior P
J Biol Chem; 2021; 296():100135. PubMed ID: 33268377
[TBL] [Abstract][Full Text] [Related]
17. Dynamics of SARS-CoV-2 mutations reveals regional-specificity and similar trends of N501 and high-frequency mutation N501Y in different levels of control measures.
Justo Arevalo S; Zapata Sifuentes D; J Huallpa C; Landa Bianchi G; Castillo Chávez A; Garavito-Salini Casas R; Uribe Calampa CS; Uceda-Campos G; Pineda Chavarría R
Sci Rep; 2021 Sep; 11(1):17755. PubMed ID: 34493762
[TBL] [Abstract][Full Text] [Related]
18. Genomic Epidemiology and Lineage Dynamics of SARS-CoV-2 in Bulgaria: Insights from a Three-Year Pandemic Analysis.
Giovanetti M; Cella E; Ivanov I; Grigorova L; Stoikov I; Donchev D; Dimitrova R; Slavov SN; Mavian C; Fonseca V; Scarpa F; Borsetti A; Korsun N; Trifonova I; Dobrinov V; Kantardjiev T; Christova I; Ciccozzi M; Alexiev I
Viruses; 2023 Sep; 15(9):. PubMed ID: 37766330
[TBL] [Abstract][Full Text] [Related]
19. Evolving geographic diversity in SARS-CoV2 and in silico analysis of replicating enzyme 3CL
Chitranshi N; Gupta VK; Rajput R; Godinez A; Pushpitha K; Shen T; Mirzaei M; You Y; Basavarajappa D; Gupta V; Graham SL
J Transl Med; 2020 Jul; 18(1):278. PubMed ID: 32646487
[TBL] [Abstract][Full Text] [Related]
20. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
